Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice
about
Evidence from studies in rodents and in isolated adipocytes that agonists of the chemerin receptor CMKLR1 may be beneficial in the treatment of type 2 diabetes.Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesityChemerin in peritoneal sepsis and its associations with glucose metabolism and prognosis: a translational cross-sectional study.Animal Models Correlating Immune Cells for the Development of NAFLD/NASH.Chemokine-Like Receptor 1 mRNA Weakly Correlates with Non-Alcoholic Steatohepatitis Score in Male but Not Female IndividualsAdipokines in Liver Cirrhosis.Genome-wide linkage and association analysis of cardiometabolic phenotypes in Hispanic Americans.International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function.PI3K inhibition protects mice from NAFLD by down-regulating CMKLR1 and NLRP3 in Kupffer cells.Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity.Chemerin: a multifaceted adipokine involved in metabolic disorders.The impact of chemerin or chemokine-like receptor 1 loss on the mouse gut microbiome
P2860
Q35081441-B098207B-F22D-48D8-AD9D-34E32A5C68F1Q35113836-12A0A416-D9AA-4A1D-B7E1-A700952970F0Q35922861-73CBE8C7-1E9E-4B68-B8AB-AB4C9941B1EDQ36245960-81258F9C-CF47-465E-BF83-46BB35D01601Q37210183-9FF45D69-E158-49AF-ABC0-B387793FA9DFQ39404643-63D6C844-58C2-41AB-B526-2BFC82466C5EQ40617961-E702E86B-C799-4701-BF25-DCB3B81D1B73Q47253151-9F84BAA4-1791-41F8-9554-ACA5CB519B83Q47805260-169E9A3B-DCFE-493A-9265-472E3E7D4979Q49144853-0E537F58-229E-4DB7-876F-C7C6148147FDQ55435289-B90DE090-494B-45AF-8997-B4CF5B85DE75Q57158141-E7DB2806-61E1-4AB7-AC3A-028AC6A9525C
P2860
Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Chemokine-like receptor 1 defi ...... ic fatty liver disease in mice
@ast
Chemokine-like receptor 1 defi ...... ic fatty liver disease in mice
@en
type
label
Chemokine-like receptor 1 defi ...... ic fatty liver disease in mice
@ast
Chemokine-like receptor 1 defi ...... ic fatty liver disease in mice
@en
prefLabel
Chemokine-like receptor 1 defi ...... ic fatty liver disease in mice
@ast
Chemokine-like receptor 1 defi ...... ic fatty liver disease in mice
@en
P2093
P2860
P1433
P1476
Chemokine-like receptor 1 defi ...... ic fatty liver disease in mice
@en
P2093
Alain de Bruin
Bart van de Sluis
Debby P Y Koonen
Dianne J Delsing
Henk van der Molen
Jan Albert Kuivenhoven
Marcela Aparicio Vergara
Marten H Hofker
Nanda Gruben
Niels J Kloosterhuis
P2860
P304
P356
10.1371/JOURNAL.PONE.0096345
P407
P577
2014-04-29T00:00:00Z